CDH2 and cervical carcinoma: Moreover, decreased migratory ability was observed in cervical cancer cells derived CSCs along with down-regulated expression of N-cadherin and Vimentin and up-regulated E-cadherin after treatment with 10, 20, and 30 μM zoledronic acid, respectively (Fig. 3d-f).